Help us improve this page by adding information.
Visit our Writing Guide or this topic page for additional help.
Visit our Writing Guide or this topic page for additional help.
Timeline
November 30, 2017
Semma Therapeutics raises a $114,000,000 series B round from Eight Roads Ventures.
Funding rounds
People
Name
Role
LinkedIn
Further reading
Title
Author
Link
Type
Date
A startup looking to reverse type 1 diabetes just raised $114 million
Lydia Ramsey
Web
R.I. biotech firm, CytoSolv, acquired by Semma Therapeutics
Richard Asinof
Web
What You Need to Know About Semma Therapeutics
BioSpace
Web
Documentaries, videos and podcasts
Title
Date
Link
Companies
Company
CEO
Location
Products/Services
News
Title
Author
Date
Publisher
Description
Research and Markets
January 7, 2021
www.prnewswire.com:443
/PRNewswire/ -- The "Stem Cell Therapy Global Market Report 2020-30: COVID-19 Growth and Change" report has been added to ResearchAndMarkets.com's offering....
Is a
CompanyCompany attributes
Biotechnology
Healthcare
Regenerative medicine
Stem cell
Cambridge, Massachusetts
United StatesCrunchbase
Novartis
Eight Roads Ventures
JDRF T1D FundFounded date
2015
Total funding amount (USD)
114,000,000
Latest funding round date
November 30, 2017
Latest funding type
Series B round
